Metamfetamine
RxNorm 6816
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 6816 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Metamfetamine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Desoxyephedrine
(Atom ID: 2722871)
SYPrescribable
Synonym (SY):
Metamfetamine
(Atom ID: 9270642)
SYPrescribable
Synonym (SY):
Metamfetamine
(Atom ID: 10806865)
FNPrescribable
Full form of descriptor (FN):
Metamfetamine (substance)
(Atom ID: 10301480)
SYPrescribable
Synonym (SY):
Metamfetamine-containing product
(Atom ID: 11825812)
INPrescribable
Ingredient (IN):
Methamphetamine
(Atom ID: 12253326)
PTPrescribable
Designated preferred name (PT):
Methamphetamine
(Atom ID: 10806935)
PTPrescribable
Designated preferred name (PT):
Methamphetamine-containing product
(Atom ID: 11825818)
FNPrescribable
Full form of descriptor (FN):
Product containing metamfetamine (medicinal product)
(Atom ID: 9259557)
Patient Education
Methamphetamine
Methamphetamine is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children. Methamphetamine is also used for a limited period of time (a few weeks) along with a reduced calorie diet and an exercise plan for weight loss in obese people unable to lose weight. Methamphetamine is in a class of medications called central nervous system stimulants. It works by changing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.